Production Featured Articles

  1. In Vivo Manufacturing: When The Body Becomes The Bioreactor 5/15/2026

    Breakthrough therapies are reshaping medicine, but manufacturing complexity is holding them back. Discover how rethinking production and delivery could expand reach and improve patient experience.

  2. Enhancing Safety In Drug Substance Synthesis: A Smart Approach To Chemical Design 5/6/2026

    Discover how safety‑by‑design principles in chemical synthesis help control exothermic reactions, reduce scale‑up risk, and enable safer, more reliable manufacturing of complex drug substances.

  3. Gaining An Edge In GLP-1 Production 5/5/2026

    The shortage-driven production of GLP-1 drugs of the past few years is giving way to a long-term operation model characterized by digital enablement and supply chain resilience.

  4. How Rheology Ensures Effective Quality Control 5/1/2026

    Rheology connects formulation science to manufacturing reality. By tracking how drugs flow and respond to stress, teams can prevent batch variability and protect dosage performance.

  5. The Stepwise Path Lilly Mapped From Paper To Digital Logbooks 4/30/2026

    Eli Lilly and Company started at the front lines, on the shop floor gathering operator input, when switching from paper to digital logbooks.

  6. Embedded AI Is The Future Of Biopharmaceutical Recipe Creation 4/28/2026

    AI-assisted recipe creation works differently across MES and DCS environments. Where the AI sits in the automation architecture, embedded or added on, shapes how well it handles GMP-scale complexity.

  7. 3 Innovations For Reducing Risk In Continuous Downstream Bioprocessing 4/21/2026

    Batch-to-continuous transitions in downstream bioprocessing carry real risks. Here's how advanced analytics, smarter buffer strategies, and single-use systems are changing that calculus.

  8. Manufacturing Readiness Is The Next Frontier In Life Sciences AI 4/20/2026

    As AI compresses discovery timelines, molecules reach commercial manufacturing sooner and with less runway. Readiness starts upstream, where process knowledge transfers and execution data becomes the foundation for trustworthy AI.

  9. The Evolving Landscape Of HPAPI Contract Manufacturing 4/20/2026

    Surging demand for highly potent drugs is driven by targeted therapies, stricter containment standards, increased outsourcing, and the need for specialized, compliant manufacturing.

  10. The Future Of Sustainable Amorphous Dispersion Development 4/15/2026

    Sustainable amorphous dispersion cuts cost, risk, and timelines by removing solvent waste, simplifying manufacturing, strengthening supply chains, and scaling efficiently to commercialization.